Cartesian Therapeutics Inc (RNAC)
26.41
+0.07
(+0.27%)
USD |
NASDAQ |
May 17, 16:00
26.41
0.00 (0.00%)
After-Hours: 20:00
Cartesian Therapeutics Total Assets (Quarterly): 325.21M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 325.21M |
| December 31, 2023 | 305.05M |
| September 30, 2023 | 106.03M |
| June 30, 2023 | 139.51M |
| March 31, 2023 | 155.69M |
| December 31, 2022 | 165.89M |
| September 30, 2022 | 178.26M |
| June 30, 2022 | 188.07M |
| March 31, 2022 | 145.70M |
| December 31, 2021 | 159.88M |
| September 30, 2021 | 167.16M |
| June 30, 2021 | 180.52M |
| March 31, 2021 | 176.75M |
| December 31, 2020 | 165.44M |
| September 30, 2020 | 181.00M |
| June 30, 2020 | 75.21M |
| March 31, 2020 | 88.80M |
| Date | Value |
|---|---|
| December 31, 2019 | 99.57M |
| September 30, 2019 | 39.54M |
| June 30, 2019 | 46.95M |
| March 31, 2019 | 62.48M |
| December 31, 2018 | 44.48M |
| September 30, 2018 | 60.32M |
| June 30, 2018 | 73.44M |
| March 31, 2018 | 89.94M |
| December 31, 2017 | 101.10M |
| September 30, 2017 | 109.72M |
| June 30, 2017 | 117.02M |
| March 31, 2017 | 73.86M |
| December 31, 2016 | 89.30M |
| September 30, 2016 | 85.78M |
| June 30, 2016 | 91.32M |
| March 31, 2016 | 34.72M |
| December 31, 2015 | 42.82M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
39.54M
Minimum
Sep 2019
325.21M
Maximum
Mar 2024
154.51M
Average
162.66M
Median
Total Assets (Quarterly) Benchmarks
| Marinus Pharmaceuticals Inc | 137.35M |
| Adial Pharmaceuticals Inc | 4.737M |
| Poseida Therapeutics Inc | 262.58M |
| Biomea Fusion Inc | 168.49M |
| NovaBay Pharmaceuticals Inc | 5.357M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 442.01M |
| Shareholders Equity (Quarterly) | -116.80M |
| Current Ratio | 3.031 |
| Net Debt Paydown Yield | 4.88% |